Form 8-K - Current report:
SEC Accession No. 0001140361-25-022375
Filing Date
2025-06-13
Accepted
2025-06-13 08:21:11
Documents
18
Period of Report
2025-06-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20050461x3_8k.htm   iXBRL 8-K 33852
2 EXHIBIT 1.1 ny20050461x3_ex1-1.htm EX-1.1 209966
3 EXHIBIT 5.1 ny20050461x3_ex5-1.htm EX-5.1 14646
4 EXHIBIT 99.1 ny20050461x3_ex99-1.htm EX-99.1 19906
5 EXHIBIT 99.2 ny20050461x3_ex99-2.htm EX-99.2 20922
9 ny20050461x3_ex5-1img01.jpg GRAPHIC 6575
10 ny20050461x3_ex99img01.jpg GRAPHIC 18382
  Complete submission text file 0001140361-25-022375.txt   534015

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA insm-20250611.xsd EX-101.SCH 3859
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20250611_lab.xml EX-101.LAB 21966
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20250611_pre.xml EX-101.PRE 16040
21 EXTRACTED XBRL INSTANCE DOCUMENT ny20050461x3_8k_htm.xml XML 4056
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 251044792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)